These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 82752)

  • 21. Feasibility of neonatal screening for Duchenne muscular dystrophy.
    Skinner R; Emery AE; Scheuerbrandt G; Syme J
    J Med Genet; 1982 Feb; 19(1):1-3. PubMed ID: 7069739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Muscular dystrophy: Duchenne and Becker-Kiener types].
    Kuhn E
    Dtsch Med Wochenschr; 1979 Dec; 104(51):1817-20. PubMed ID: 391521
    [No Abstract]   [Full Text] [Related]  

  • 24. False elevation of amniotic fluid enzymes of relevance for prenatal diagnosis: creatine kinase measurement in relation to Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(1):35-42. PubMed ID: 6728825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis.
    Plauchu H; Dorche C; Cordier MP; Guibaud P; Robert JM
    Lancet; 1989 Mar; 1(8639):669. PubMed ID: 2564481
    [No Abstract]   [Full Text] [Related]  

  • 26. Errors in plasma creatine kinase estimations on fetal blood samples resulting from contamination with amniotic fluid and maternal blood: relevance for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(2):119-34. PubMed ID: 6739434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 28. [Limb-girdle muscular dystrophy in MRI].
    Herzog H; Schröder RJ
    Rofo; 2003 Oct; 175(10):1432-4. PubMed ID: 14556115
    [No Abstract]   [Full Text] [Related]  

  • 29. Somatic mosaicism at the Duchenne locus.
    Lebo RV; Olney RK; Golbus MS
    Am J Med Genet; 1990 Oct; 37(2):187-90. PubMed ID: 1978985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
    Gale AN; Murphy EA
    J Chronic Dis; 1978 Feb; 31(2):101-9. PubMed ID: 659567
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyruvate kinase in fetal plasma and amniotic fluid unsuccessful for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1984 Jun; 18(2):231-5. PubMed ID: 6465199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnosis of Duchenne muscular dystrophy.
    Beckmann R; Sauer M; Ketelsen UP; Scheuerbrandt G
    Lancet; 1978 Jul; 2(8080):105. PubMed ID: 78271
    [No Abstract]   [Full Text] [Related]  

  • 34. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy.
    Bushby KM; Hill A; Steele JG
    Lancet; 1999 Feb; 353(9152):557-8. PubMed ID: 10028989
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for Duchenne muscular dystrophy.
    Fenton-May J; Bradley DM; Sibert JR; Smith R; Parsons EP; Harper PS; Clarke A
    Arch Dis Child; 1994 Jun; 70(6):551-2. PubMed ID: 8048834
    [No Abstract]   [Full Text] [Related]  

  • 39. A new screening test for serum creatine phosphokinase.
    Paterson Y
    Clin Chim Acta; 1971 Oct; 34(3):373-6. PubMed ID: 5119330
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma creatine kinase and myoglobin levels, before and after abortion, in human fetuses at risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1983 Jul; 15(3):475-82. PubMed ID: 6881213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.